Aneuploidy-Sperm 13, 18, 21, X and Y by FISH

Reproductive

Report in 192Hrs

At Home

No Fasting Required

Details

Detects chromosomal abnormalities in sperm using FISH probes.

₹5,180₹7,400

30% OFF

Aneuploidy-Sperm 131821X and Y by FISH - Comprehensive Medical Test Guide

Section 1: Why is it done?
- Test Overview: This test uses Fluorescence In Situ Hybridization (FISH) technology to detect chromosomal abnormalities (aneuploidies) in sperm cells, specifically analyzing the X and Y sex chromosomes. It identifies abnormalities in sperm chromosome number and distribution.
- Primary Indications for Testing: Male infertility evaluation and assessment of sperm quality
- Recurrent pregnancy loss or recurrent miscarriages associated with male factor
- Abnormal semen analysis findings (oligospermia, asthenospermia, or teratospermia)
- Suspected chromosomal abnormalities in male partners undergoing fertility treatment
- Assessment of sperm quality prior to assisted reproductive techniques (ART) such as IVF or ICSI
- Evaluation of potential chromosomal mosaicism in ejaculate
- Typical Timing and Circumstances: Performed during initial fertility workup or after abnormal semen analysis; may be repeated after therapeutic interventions; typically performed on fresh or cryopreserved semen samples
Section 2: Normal Range
- Normal Reference Values: X and Y chromosome aneuploidy rate should be <5-7% of sperm cells analyzed
- Normal diploid sperm (containing both X and Y): <1% of cells
- Nullisomic sperm (lacking both X and Y): <1% of cells
- XY sperm: 45-55% (haploid, normal)
- X-bearing sperm: 45-55% (haploid, normal)
- Units of Measurement: Percentage (%) of sperm cells with specific chromosome patterns
- Result Interpretation:
- Normal: Aneuploidy rates within expected ranges; indicates acceptable sperm chromosomal quality
- Abnormal: Aneuploidy rate >7%; indicates elevated chromosomal abnormalities in sperm
- Borderline: 5-7% aneuploidy; warrants careful interpretation and possible repeat testing
Section 3: Interpretation
- Result Value Interpretation:
- Normal Results (<5% aneuploidy): Indicates normal chromosomal segregation during meiosis; acceptable sperm quality for natural conception or ART; low risk of chromosomal abnormalities in offspring
- Elevated X and Y Aneuploidy (>7%): Suggests meiotic dysfunction or abnormal spermatogenesis; may indicate increased risk of aneuploid embryos; associated with male factor infertility; may require genetic counseling and consideration of ICSI or PGD/PGT-A
- Specific Chromosome Pattern Abnormalities:
- Elevated YY sperm: Suggests problems with Y chromosome segregation; may indicate higher risk of sex chromosome aneuploidies (Klinefelter syndrome, Turner syndrome)
- Elevated XX sperm: May indicate problems during the second meiotic division; associated with increased risk of female sex chromosome trisomy
- Elevated nullisomic sperm (00): Indicates meiotic non-disjunction events; may suggest significant reproductive risk
- Factors Affecting Results:
- Age of the male partner (advancing paternal age increases aneuploidy)
- Lifestyle factors (smoking, alcohol use, heat exposure, environmental toxins)
- Underlying genetic predisposition or chromosomal structural abnormalities
- Recent illness, fever, or systemic disease affecting spermatogenesis
- Medications affecting reproductive function
- Sample quality, storage conditions, and processing methodology
- Clinical Significance: Elevated sperm aneuploidy is associated with reduced fertilization rates, increased embryonic loss, and higher risk of chromosomally abnormal offspring; strong predictor of ART outcome and potential need for modified treatment strategies
Section 4: Associated Organs
- Primary Organ Systems Involved: Male reproductive system, specifically testes and associated structures
- Conditions Associated with Abnormal Results:
- Male factor infertility and oligospermia
- Azoospermia or severely reduced sperm count
- Teratozoospermia (abnormal sperm morphology)
- Asthenozoospermia (reduced sperm motility)
- Meiotic dysfunction or arrested spermatogenesis
- Chromosomal structural abnormalities (balanced translocations, inversions)
- Diseases and Conditions Diagnosed:
- Primary male infertility and unexplained infertility
- Recurrent miscarriage of chromosomally abnormal embryos
- History of births with sex chromosome trisomies (XXY, XXX, XYY)
- Complications Associated with Abnormal Results:
- Increased risk of aneuploid embryos and chromosomally abnormal offspring
- Reduced fertility and need for assisted reproductive interventions
- Higher rates of miscarriage and implantation failure in both natural and assisted conception
- Potential for birth defects related to sex chromosome aneuploidies (Klinefelter, Turner, Trisomy X syndromes)
- Psychological and emotional impact of repeated fertility failures
Section 5: Follow-up Tests
- Recommended Additional Testing:
- Comprehensive Semen Analysis (including volume, concentration, motility, morphology) - standard initial test if not already performed
- Karyotype analysis (46,XY) - to identify balanced chromosomal abnormalities or mosaicism in the male partner
- Additional FISH panels (autosomal aneuploidy testing for chromosomes 13, 18, 21, 22) - if clinically indicated and resources available
- DNA fragmentation testing - to assess sperm DNA integrity, important for fertility prognosis
- Hormonal evaluation (FSH, LH, testosterone) - to assess testicular function and pituitary-gonadal axis
- Genetic counseling and assessment - recommended for couples with elevated sperm aneuploidy
- Further Investigations if Abnormal:
- Testicular imaging (ultrasound) - to evaluate testicular volume, echotexture, and identify structural abnormalities
- Urological consultation - for evaluation of obstruction, varicocele, or other structural abnormalities
- Whole genome sequencing or copy number variation (CNV) analysis - if structural chromosomal abnormalities suspected
- Y-chromosome microdeletion analysis - for severely reduced sperm count or azoospermia
- Reproductive Options and Considerations:
- Preimplantation genetic testing for aneuploidies (PGT-A) or preimplantation genetic testing for monogenic disorders (PGT-M) in conjunction with IVF
- Intracytoplasmic sperm injection (ICSI) - often recommended with elevated aneuploidy to maximize fertilization potential
- Donor sperm consideration - in cases of severely elevated aneuploidy affecting multiple chromosomes
- Monitoring Frequency: Repeat testing may be considered after 2-3 months if initial results are abnormal or borderline, or after therapeutic lifestyle modifications; baseline testing typically performed once at start of fertility evaluation unless clinical circumstances change
Section 6: Fasting Required?
- Fasting Requirement: NO - Fasting is not required for this test
- Patient Preparation Instructions:
- Semen Sample Collection:
  - Abstinence from sexual activity (ejaculation) for 2-5 days prior to collection (typically 3 days is recommended for optimal results)
  - Collection via masturbation into a sterile, wide-mouth container provided by the laboratory
  - Complete collection of the entire ejaculate (including initial portion which is most concentrated with sperm)
  - Timely delivery to laboratory (typically within 60 minutes of collection for optimal sperm viability)
  - Maintenance of sample at room temperature during transport; do not refrigerate or freeze unless instructed
- Medications to Avoid:
- No specific medications are contraindicated immediately before test collection; however, inform laboratory of any medications currently being taken as some may affect sperm parameters
- Chronic medications should not be discontinued without consulting prescribing physician
- Lifestyle Modifications (Weeks Prior to Testing):
- Avoid smoking and limit alcohol consumption (optimally avoid for 2-3 months as spermatogenesis takes ~74 days)
- Maintain adequate hydration and nutritious diet rich in antioxidants
- Avoid excessive heat exposure (hot baths, saunas, tight-fitting clothing) which can affect sperm production
- Regular physical activity and stress reduction techniques recommended
- Special Instructions:
- Inform laboratory of any recent illnesses or fevers (within preceding 2-3 months) as they may temporarily affect sperm parameters
- Do not use lubricants, condoms with spermicide, or saliva during sample collection; approved collection containers should be used
- Specimen must be properly labeled with patient identification and collection date/time for accurate results

How our test process works!